Výsledky vyhledávání - "Elvira Buxó"

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

Publikováno v: PLoS ONE, Vol 15, Iss 7, p e0235848 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
PLoS ONE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Background Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice. Materials and methods The study populati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3ced905477a64fe5f76bc6895f20eb
https://hdl.handle.net/20.500.13003/11571

Zobrazit plný text záznamu

Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?

Autor: Nuria Sánchez, Angels Ginès, Jaime Ortín, Maria Mayoral, P. Perlaza, David Fuster, Elvira Buxó, Domenico Rubello, Gloria Fernández-Esparrach, Cristina Ruiz, Patrick M. Colletti, Mario Pagés

Publikováno v: Clinical Nuclear Medicine. 43:402-410

PURPOSE The aim of this study was to evaluate F-FDG PET/CT compared with conventional imaging techniques in the clinical management of patients with locally advanced gastric cancer (LAGC). METHODS A prospective study between January 2010 and December

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d1a7ae7e29273415cb5b9b5c5ff4be
https://doi.org/10.1097/rlu.0000000000002028

Zobrazit plný text záznamu

Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study

Autor: Miguel Caballero, Iván Victoria, Juan J. Grau, Marcial García-Morillo, Aaron E. Sosa, Elvira Buxó, Òscar Reig

Publikováno v: Annals of Otology, Rhinology & Laryngology. 127:456-462

Objectives: In the EXTREME trial, a combination of cisplatin or carboplatin plus 5-fluorouracil (5-FU) and cetuximab was superior to cisplatin/carboplatin plus 5-FU for first-line treatment of recurrent or metastatic head and neck squamous cell carci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89beab233f00736d2b5a3e7a9607e3dc
https://doi.org/10.1177/0003489418778066

Zobrazit plný text záznamu

Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis

Publikováno v: Journal of Geriatric Oncology. 9:254-264

OBJECTIVE: Advanced gastric cancer (AGC) is a common neoplasm in older adults. Nevertheless, there are few specific management data in the literature. The aim of this study was to assess non-inferiority of survival and efficacy-related outcomes of ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f78c2f511de7e2c12d4079b5f2c244
https://doi.org/10.1016/j.jgo.2017.11.008

Zobrazit plný text záznamu

The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer

Autor: Elvira Buxó, Miguel Caballero, Paula Mackers, José Luis Blanch, Òscar Reig, Juan J. Grau, Pilar Navarrete

Publikováno v: Oncology. 93:75-82

Objectives: To analyze the role of audiometry in considering change to a less ototoxic treatment in head and neck cancer (HNC) patients. Methods: Consecutive patients prescribed high-dose cisplatin (100 mg/m2) between January 2013 and February 2015 w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece8e0846039a750b1c7ace7c709ab99
https://doi.org/10.1159/000468522

Zobrazit plný text záznamu

1496TiP Phase I study evaluating safety and tolerability of AMG 910, a half-life extended bispecific T cell engager targeting claudin-18.2 (CLDN18.2) in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma

Autor: Richard Greil, Elvira Buxó, Caio Max Sao Pedro Rocha Lima, Joseph Chao, Sabine Stienen, Sylvie Lorenzen, Kohei Shitara, Farshid Dayyani, Florian Lordick, Volker Heinemann, H.W.M. van Laarhoven

Publikováno v: Annals of Oncology. 31:S928-S929

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b51c472012f350cea031c5d1eb0e4d7
https://doi.org/10.1016/j.annonc.2020.08.2002

Zobrazit plný text záznamu

Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma

Autor: Sebastian Casanueva, Maria Mayoral, Mario Pagés, P. Perlaza, Elvira Buxó, Domenico Rubello, David Fuster, N. Sánchez-Izquierdo, Angels Ginès, Patrick M. Colletti, José Ríos, Gloria Fernández-Esparrach

Publikováno v: Clinical nuclear medicine. 45(1)

Purpose The outcome of locally advanced adenocarcinoma of the esophagogastric junction (AEG) treated with preoperative chemoradiotherapy is heterogeneous, and favorable response to this treatment is a key factor in the patient's prognosis. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd9a55bc6242af65fb1c6da935383dc
https://pubmed.ncbi.nlm.nih.gov/31714278

Zobrazit plný text záznamu

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study

Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
BMC Cancer
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica

Background: Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy and safety in non-selected patients in a real-life setting may provide useful i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26323259b3ceea687237138c50f0db8
http://zaguan.unizar.es/record/76952

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání